Pregled bibliografske jedinice broj: 740549
Cardiometabolic aspects of polycystic ovary syndrome
Cardiometabolic aspects of polycystic ovary syndrome, 2014., diplomski rad, diplomski, Medicinski fakultet, Zagreb, Hrvatska
CROSBI ID: 740549 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cardiometabolic aspects of polycystic ovary syndrome
Autori
Ougouang, Roya
Vrsta, podvrsta i kategorija rada
Ocjenski radovi, diplomski rad, diplomski
Fakultet
Medicinski fakultet
Mjesto
Zagreb, Hrvatska
Datum
12.06
Godina
2014
Stranica
63
Mentor
Pavičić Baldani, Dinka
Ključne riječi
PCOS; Insulin resistance; Metabolic Syndrome; Cardiovascular Disease; Cardiovascular Risk Factors
Sažetak
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age. Although PCOS is diagnosed exclusively based on reproductive criteria, it is also a metabolic disorder. Insulin resistance, impaired glucose tolerance, type 2 diabetes mellitus, obesity and dyslipidemia are more common in women with PCOS than in age-comparable women without PCOS. Many of the metabolic abnormalities that manifest in PCOS are worsened by the concurrent incidence of obesity. However, some of these metabolic perturbations occur even in lean women with PCOS and therefore are rightfully recognized as intrinsic to PCOS. The intrinsic factors that produce these metabolic disturbances are reviewed in this thesis paper. The consequences of obesity and the other metabolic aberrations are also discussed. The metabolic perturbations in PCOS patients lead to chronic low grade inflammation and to cardiovascular impairments that heighten the risk of having cardiovascular disease. Therapies such as oral contraceptives and anti-androgenic medications used to manage the reproductive manifestations of PCOS may themselves be a cause of metabolic perturbations. Therefore, factors influencing the cardiometabolic side effects arising during the treatment of the non-metabolic manifestations of PCOS will also be discussed in an effort to minimize the overall cardiometabolic risk.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti